San Clemente-based cardiac device company AtaCor Medical announced a collaboration with Abbott Laboratories to develop a next ...
Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed ...
Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...
Our Lady Of Lourdes Heart Hospital relocated its Electrophysiology Lab, expanding advanced AFib and heart rhythm care for ...
Over one million people in Spain live with pacemakers, ICDs or cardiac resynchronisation devices. The introduction of the ...
In a Utah family’s telling, the story of their granddaughter’s birth is forever tied to the day her grandfather’s heart stopped and then started again. What was supposed to be a simple first visit ...
Recent research (2024-2025) consistently demonstrates the advantages of integrated AI-VR training: Knowledge Acquisition: ...
Some specialists believe there’s an even easier solution. Manuel Martínez-Sellés, head of Acute Cardiac Care at Madrid’s ...
"It is unknown at this time if there will be additional litigation surrounding this specific product," Rosalie Louis of Lynch ...
From GP appointments to A&E waiting times - what are people's experiences of the NHS in the South?
Analysts' ratings for Abbott Laboratories (NYSE:ABT) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The following table encapsulates their recent ratings, offering a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results